Back to search

Netherlands· NL-55941a1cf46b

Gaviscon Duo pepermuntsmaak 500 mg/ 213 mg/ 325 mg, suspensie voor oraal gebruik

A other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) product containing calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)), registered in Netherlands by Reckitt Benckiser Healthcare B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC A02BX

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGaviscon Duo pepermuntsmaak 500 mg/ 2…ATCA02BXREGISTER NO.NL-55941a1cf46bPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)) is registered in 5 of 19 countries.

Countries holding a registration under ATC A02BX (other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)) · ATC A02BX

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CALCIUMCARBONAAT (E 170) + NATRIUMALGINAAT (E 401) + NATRIUMWATERSTOFCARBONAAT (E 500 (II))
Manufacturer
Reckitt Benckiser Healthcare B.V.
Country
Netherlands (NL)
ATC code
A02BX
ATC class
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130340

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4cb3fc20-2dfe-481d-843f-6aba67e54867
GET /v1/drugs/4cb3fc20-2dfe-481d-843f-6aba67e54867?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130340_smpc.pdf",
  "strength": null,
  "atc_label": "Other Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130340",
  "excipients": [
    "CARBOMEER 974P",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "PEPERMUNTSMAAKSTOF",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CALCIUMCARBONAAT (E 170)",
    "NATRIUMALGINAAT (E 401)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130340.pdf",
  "authorised_at": "2024/05/23",
  "procedure_number": "NL/H/5583/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "130340",
  "additional_monitoring": "N"
}

See everything about calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.